Meirav Pevsner

Title: Meirav Pevsner: Innovator in Immunomodulation

Introduction

Meirav Pevsner is a notable inventor based in Karmiel, Israel. He has made significant contributions to the field of immunology, particularly through his innovative research and patents. His work focuses on the modulation of immune responses and the treatment of inflammatory diseases.

Latest Patents

Meirav Pevsner holds a patent for "HSP60, HSP60 peptides and T cell vaccines for immunomodulation." This invention provides novel uses for peptide p277—positions 437-460 of human heat shock protein 60 (HSP60)—in the modulation of immune responses and inflammatory diseases. The patent further outlines methods for treating, preventing, or ameliorating symptoms of T cell-mediated inflammatory and autoimmune disorders, including hepatic disorders. The invention includes administering a composition with HSP60, p277, and their derivatives to subjects in need. Additionally, T cell vaccination methods for treating or preventing T cell-mediated disorders are disclosed.

Career Highlights

Meirav Pevsner is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in immunology. His work has garnered attention for its potential applications in treating various immune-related conditions.

Collaborations

Meirav has collaborated with notable colleagues, including Irun R Cohen and Alexandra Zanin-Zhorov, who is a prominent female researcher in the field. Their combined efforts contribute to the advancement of immunological research and innovation.

Conclusion

Meirav Pevsner's contributions to immunomodulation through his patent and research highlight his role as an influential inventor in the field. His work has the potential to impact the treatment of autoimmune and inflammatory disorders significantly.